Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
PUT
Zoetis
ZTS
$30.5B
| $448K | ﹤0.01% |
10,100
-483,100
| -98% | -$20.5M |
|
4777
Companhia Siderúrgica Nacional
SID
$1.23B
| $447K | ﹤0.01% |
226,625
-1,558,700
| -87% | -$2.05M |
|
|
BAS
4778
DELISTED
Basis Energy Services, Inc.
BAS
| $446K | ﹤0.01% |
283
-2,058
| -88% | -$2.68M |
|
4779
A10 Networks
ATEN
$1.93B
| $444K | ﹤0.01% |
74,988
+44,912
| +149% | +$268K |
|
|
VPU
4780
Vanguard Utilities ETF
VPU
$8.36B
| $444K | ﹤0.01% |
4,130
-39
| -0.9% | -$3.9K |
|
|
QEP
4781
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $444K | ﹤0.01% |
31,500
-11,700
| -27% | -$135K |
|
4782
Anika Therapeutics
ANIK
$287M
| $443K | ﹤0.01% |
9,903
-7,517
| -43% | -$305K |
|
4783
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
| $443K | ﹤0.01% |
15,716
-423
| -3% | -$10.8K |
|
4784
Malibu Boats
MBUU
$567M
| $442K | ﹤0.01% |
+26,945
| New | +$393K |
|
4785
PUT
Chubb
CB
$135B
| $441K | ﹤0.01% |
3,700
-11,000
| -75% | -$1.26M |
|
4786
Marcus & Millichap
MMI
$1.19B
| $441K | ﹤0.01% |
17,372
-13,084
| -43% | -$307K |
|
|
CSR
4787
Centerspace
CSR
$952M
| $440K | ﹤0.01% |
6,054
-4,019
| -40% | -$264K |
|
|
LAYN
4788
DELISTED
Layne Christensen Co
LAYN
| $440K | ﹤0.01% |
61,186
-42,402
| -41% | -$247K |
|
4789
CALL
Cigna
CI
$74.6B
| $439K | ﹤0.01% |
3,200
-147,800
| -98% | -$20.3M |
|
4790
CALL
MiMedx Group
MDXG
$633M
| $439K | ﹤0.01% |
50,200
-9,800
| -16% | -$81.4K |
|
|
4791
PUT
MiMedx Group
MDXG
$633M
| $439K | ﹤0.01% |
50,200
-9,800
| -16% | -$81.4K |
|
|
INVN
4792
CALL
DELISTED
Invensense Inc
INVN
| $439K | ﹤0.01% |
52,300
+4,300
| +9% | +$34.1K |
|
4793
iShares MSCI Belgium ETF
EWK
$165M
| $438K | ﹤0.01% |
+24,801
| New | +$420K |
|
4794
Gogo Inc
GOGO
$491M
| $438K | ﹤0.01% |
39,840
-50,391
| -56% | -$638K |
|
|
DLA
4795
DELISTED
Delta Apparel Inc.
DLA
| $438K | ﹤0.01% |
22,904
+6,744
| +42% | +$104K |
|
4796
CALL
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $437K | ﹤0.01% |
22,100
-10,200
| -32% | -$187K |
|
4797
Daktronics
DAKT
$1.04B
| $436K | ﹤0.01% |
+55,131
| New | +$424K |
|
4798
PUT
Quest Diagnostics
DGX
$26.3B
| $436K | ﹤0.01% |
6,100
+3,600
| +144% | +$241K |
|
|
LPNT
4799
CALL
DELISTED
LifePoint Health, Inc.
LPNT
| $436K | ﹤0.01% |
6,300
+6,200
| +6,200% | +$414K |
|
4800
CALL
Ecolab
ECL
$79.9B
| $435K | ﹤0.01% |
+3,900
| New | +$414K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.